Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway

Brief intermittent episodes of ischemia and reperfusion, at the onset of reperfusion after a prolonged period of ischemia, confer cardioprotection, a phenomenon termed “ischemic postconditioning” (Postcond). We hypothesized that this phenomenon may just represent a modified form of reperfusion that activates the reperfusion injury salvage kinase (RISK) pathway. Isolated perfused rat hearts were subjected to: (a) 35 minutes of ischemia and 120 minutes of reperfusion, and infarct size was determined by tetrazolium staining; or (b) 35 minutes of ischemia and 7 minutes of reperfusion, and the phosphorylation states of Akt, endothelial NO synthase (eNOS), and p70S6K were determined. Postcond reduced infarct size from 51.2±3.4% to 31.5±4.1% (P<0.01), an effect comparable with ischemic preconditioning (IPC; 27.5±2.3%; P<0.01). Of interest, the combined protective effects of IPC and Postcond were not additive (30.1±4.8% with IPC+Postcond; P=NS). Inhibiting phosphatidylinositol 3-kinase (PI3K) at reperfusion using LY or Wortmannin (Wort) during the first 15 minutes of reperfusion completely abolished Postcond-induced protection (31.5±4.1% with Postcond versus 51.7±4.5% with Postcond+LY, P<0.01; 56.2±10.1% with Postcond+ Wort; P<0.01), suggesting that Postcond protects the heart by activating PI3K–Akt. Western blot analysis demonstrated that Postcond induced a significant increase in phosphorylation of Akt, eNOS, and p70S6K in an LY- and Wort-sensitive manner. In conclusion, we show for the first time that ischemic Postcond protects the myocardium by activating the prosurvival kinases PI3K–Akt, eNOS, and p70S6K in accordance with the RISK pathway.

[1]  R. Guyton,et al.  Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. , 2004, Cardiovascular research.

[2]  D. Yellon,et al.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. , 2004, Cardiovascular research.

[3]  J. Auer,et al.  Small left ventricular aneurysms in patients with ventricular tachyarrhythmias and normal coronary arteriograms. , 2003, Circulation.

[4]  P. Fitzgerald,et al.  Tako-tsubo-like left ventricular dysfunction. , 2003, Circulation.

[5]  M. Duchen,et al.  Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. , 2003, Cardiovascular research.

[6]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[7]  M. Mocanu,et al.  PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. , 2002, Journal of Molecular and Cellular Cardiology.

[8]  D. Yellon,et al.  Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.

[9]  Fuminori Tsuruta,et al.  The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria* , 2002, The Journal of Biological Chemistry.

[10]  H. Sato,et al.  Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation. , 1997, The Annals of thoracic surgery.

[11]  M. Balakirev,et al.  Modulation of the mitochondrial permeability transition by nitric oxide. , 1997, European journal of biochemistry.

[12]  A. Halestrap,et al.  Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. , 1995, The Biochemical journal.

[13]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.